Literature DB >> 23895799

Ring 2 chromosome associated with failure to thrive, microcephaly and dysmorphic facial features.

Arelí López-Uriarte1, Fabiola Quintero-Rivera, Beatriz de la Fuente Cortez, Viviana Gómez Puente, María Del Roble Velazco Campos, Laura E Martínez de Villarreal.   

Abstract

We report here a child with a ring chromosome 2 [r(2)] associated with failure to thrive, microcephaly and dysmorphic features. The chromosomal aberration was defined by chromosome microarray analysis, revealing two small deletions of 2p25.3 (139 kb) and 2q37.3 (147 kb). We show the clinical phenotype of the patient, using a conventional approach and the molecular cytogenetics of a male with a history of prenatal intrauterine growth restriction (IUGR), failure to thrive, microcephaly and dysmorphic facial features. The phenotype is very similar to that reported in other clinical cases with ring chromosome 2.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CMA; CNV; Chromosome microarray analysis; DNA; Dysmorphic facial features; FISH; Failure to thrive; G-bands after trypsin and Giemsa; GTG; ISCN; IUGR; International System for Human Cytogenetic Nomenclature; Microcephaly; Molecular cytogenetics; Ring 2 chromosome; SD; chromosomal microarray analysis; copy number variation; deoxyribonucleic acid; fluorescence in situ hybridization; intrauterine growth restriction; long arm of a chromosome; p; q; short arm of a chromosome; standard deviation

Mesh:

Year:  2013        PMID: 23895799     DOI: 10.1016/j.gene.2013.06.056

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Clinico-radiological and molecular characterization of a child with ring chromosome 2 presenting growth failure, microcephaly, kidney and brain malformations.

Authors:  Mariasavina Severino; Andrea Accogli; Giorgio Gimelli; Andrea Rossi; Svetlana Kotzeva; Maja Di Rocco; Patrizia Ronchetto; Cristina Cuoco; Elisa Tassano
Journal:  Mol Cytogenet       Date:  2015-03-05       Impact factor: 2.009

2.  A new patient with a terminal de novo 2p25.3 deletion of 1.9 Mb associated with early-onset of obesity, intellectual disabilities and hyperkinetic disorder.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Sergio Zanini
Journal:  Mol Cytogenet       Date:  2014-08-05       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.